STEPHEN ROBERT CHOW
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology JACKSON, MS NPI 1558774174
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology MS ABBVIE INC. All categories
General Payments — all program years on this page
$7,806.64
- Category: General Payments
- Program years: PY2018–2024
- Record count: 257
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,029.46 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,029.46 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $314.08 | 18 |
| Janssen Biotech, Inc. | $147.05 | 7 |
| Takeda Pharmaceuticals U.S.A., Inc. | $108.61 | 5 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $77.32 | 4 |
| Merck Sharp & Dohme Corporation | $56.22 | 3 |
| Ardelyx, Inc. | $41.97 | 2 |
| TerSera Therapeutics LLC | $38.32 | 1 |
| Celltrion USA Inc. | $38.05 | 2 |
| Lilly USA, LLC | $36.88 | 2 |
| Phathom Pharmaceuticals, Inc. | $35.72 | 2 |
| Regeneron Healthcare Solutions, Inc. | $28.97 | 1 |
| Madrigal Pharmaceuticals | $26.97 | 1 |
| QOL Medical, LLC | $24.05 | 1 |
| Celgene Corporation | $19.21 | 1 |
| Gilead Sciences, Inc. | $18.61 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $17.43 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.